Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5K Buy
175
+22
+14% +$486 ﹤0.01% 2402
2026
Q1
$2K Sell
153
-183
-54% -$2.69K ﹤0.01% 2259
2025
Q4
$4.25K Buy
336
+280
+500% +$4.13K ﹤0.01% 3704
2025
Q3
$861 Buy
56
+4
+8% +$64 ﹤0.01% 3844
2025
Q2
$817 Sell
52
-54
-51% -$819 ﹤0.01% 3317
2025
Q1
$2.02K Sell
106
-4
-4% -$88 ﹤0.01% 3516
2024
Q4
$2.62K Buy
110
+13
+13% +$363 ﹤0.01% 3551
2024
Q3
$2.72K Buy
97
+14
+17% +$395 ﹤0.01% 2422
2024
Q2
$2.17K Sell
83
-2
-2% -$42 ﹤0.01% 3694
2024
Q1
$1.86K Sell
85
-7
-8% -$150 ﹤0.01% 3648
2023
Q4
$2.14K Buy
92
+6
+7% +$121 ﹤0.01% 3471
2023
Q3
$1.7K Hold
86
﹤0.01% 2609
2023
Q2
$1.95K Buy
86
+15
+21% +$302 ﹤0.01% 3486
2023
Q1
$1.39K Sell
71
-26,183
-100% -$503K ﹤0.01% 2140
2022
Q4
$452K Buy
+26,254
New +$466K ﹤0.01% 1331

Other funds holding RXO

Pacer Advisors's RXO Position: Q2 2026 in Review

Pacer Advisors increased its RXO (RXO) stake by 14% in Q2 2026, buying an estimated $486 and bringing the position to 175 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Pacer Advisors first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $452K in Q4 2022. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Pacer Advisors held 175 shares of RXO worth $5K as of Q2 2026.
  • Pacer Advisors bought 22 RXO shares in Q2 2026, an estimated $486.
  • RXO made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2402 holding.
  • Pacer Advisors first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Pacer Advisors's RXO position peaked at $452K in Q4 2022.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.